U-TRIAL

U-TRIAL (Utrecht TRial Innovation ALliance) is the knowledge and expertise center that focuses on strengthening the clinical trial ecosystem within UMC Utrecht. By driving quality improvements, accelerating innovations and increasing cooperation with both internal and external stakeholders, U-TRIAL helps bring clinical trial research to a new standard. Whether you’re a researcher, Contract Research Organization (CRO), pharmaceutical company, medical devices company or a diagnostics company – U-TRIAL is your partner for excellent clinical research.

What U-TRIAL has to offer

U-TRIAL is deeply rooted in the six Strategic Research Programs of the UMC Utrecht. By working with U-TRIAL, you will have the opportunity to benefit from the strong research culture with the UMC Utrecht, especially focused on clinical trials. These opportunities include:

I. Access to excellent UMC Utrecht clinical research

We connect interested parties to established Principal Investigators (PIs) and young research talent who are experts in their field across our six strategic research programs (Brain, Infection & Immunity, Circulatory Health, Cancer, Child Health, and Regenerative Medicine & Stem Cells). Each strategic research program is represented within U-TRIAL via a Trial & Innovation Lead (TIL).

II. Access to well-characterized patient populations

We facilitate access to vast, well-defined patient populations. In 2023, UMC Utrecht cared for 235.433 unique patients. We also have an extensive collection of clinical data as well as a vast collection of unique biological specimens, contained in a biobank.

III. Increased cooperation

We initiate and maintain close relationships with Contract Research Organizations (CROs), pharmaceutical and biotech companies.

IV. U-TASK Phase 1 Unit

Collaboration between U-TRIAL and TASK: a singular Phase 1 unit for all UMC Utrecht strategic medical research programs. Currently fully operational, unique in the Netherlands.

Read more about this ground-breaking innovation

V. High-quality trials

At present, some 300 trials are in progress at the UMC Utrecht. U-TRIAL plays and has played a key role in the acquisition, start up and execution of a large portion of these trials.

VI. Access to networks

We coordinate multiple regional, national and international medical investigator networks, enhancing both initiation and efficient performance of clinical trials.

Team and organisation

Portrait Peter Gisberts
Peter Gisberts

Managing Director U-TRIAL

Learn more about Peter
Portrait Rosalie vd Boogaard
Rosalie van den Boogaard

Project Lead: Clinical Trial Ecosystem

Learn more about Rosalie
Portrait Peter Hermans
Peter Hermans

Trial and Acquisition Lead: Infection & Immunology and Child Health

Learn more about Peter
Portrait Ron de Winter
Ron de Winter

Trial and Acquisition Lead: Regenerative Medicine and Stem Cells

Learn more about Ron
Portrait Peter van de Ven
Peter van de Ven

U-TRIAL Trial Methodology Lead

Learn more about Peter
Portrait Kim Romijnders
Kim Romijnders

Project Lead: Patients inclusion

Learn more about Kim
Portrait Bart Lagerwaard
Bart Lagerwaard

Project Lead: Clinical Trial Ecosystem

Learn more about Bart

News

A person signs a set of papers.

U-TRIAL: Advancing Contract Optimization for Clinical Research

24 maart 2025 Read more

U-TRIAL: We Connect – Explore Our Annual Report 2024

27 februari 2025

U-TRIAL and innovations in trial methodology

23 november 2024

U-TRIAL Support Paves the Way for UMC Utrecht’s Role in Groundbreaking Stem Cell Heart Study

12 september 2024

Empowering PIs through collaboration, education and innovation

12 augustus 2024